Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats
- PMID: 7568041
- PMCID: PMC41076
- DOI: 10.1073/pnas.92.19.8906
Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats
Abstract
We explored how two independent variables, one genetic (i.e., specific rat strains) and another environmental (i.e., a developmental excitotoxic hippocampal lesion), contribute to phenotypic variation. Sprague-Dawley (SD), Fischer 344 (F344), and Lewis rats underwent two grades of neonatal excitotoxic damage: small and large ventral hippocampal (SVH and LVH) lesions. Locomotion was tested before puberty [postnatal day 35 (P35)] and after puberty (P56) following exposure to a novel environment or administration of amphetamine. The behavioral effects were strain- and lesion-specific. As shown previously, SD rats with LVH lesions displayed enhanced spontaneous and amphetamine-induced locomotion as compared with controls at P56, but not at P35. SVH lesions in SD rats had no effect at any age. In F344 rats with LVH lesions, enhanced spontaneous and amphetamine-induced locomotion appeared early (P35) and was exaggerated at P56. SVH lesions in F344 rats resulted in a pattern of effects analogous to LVH lesions in SD rats--i.e., postpubertal onset of hyperlocomotion (P56). In Lewis rats, LVH lesions had no significant effect on novelty- or amphetamine-induced locomotion at any age. These data show that the degree of genetic predisposition and the extent of early induced hippocampal defect contribute to the particular pattern of behavioral outcome. These results may have implications for modeling interactions of genetic and environmental factors involved in schizophrenia, a disorder characterized by phenotypic heterogeneity, genetic predisposition, a developmental hippocampal abnormality, and vulnerability to environmental stress.
Similar articles
-
Strain differences in the behavioural outcome of neonatal ventral hippocampal lesions are determined by the postnatal environment and not genetic factors.Eur J Neurosci. 2001 Sep;14(6):1030-4. doi: 10.1046/j.0953-816x.2001.01716.x. Eur J Neurosci. 2001. PMID: 11595041
-
Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia.Neuropsychopharmacology. 1993 Aug;9(1):67-75. doi: 10.1038/npp.1993.44. Neuropsychopharmacology. 1993. PMID: 8397725
-
Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less.Brain Res Bull. 2001 May 1;55(1):71-7. doi: 10.1016/s0361-9230(01)00492-0. Brain Res Bull. 2001. PMID: 11427340
-
Early environment contributes to developmental disruption of MPFC after neonatal ventral hippocampal lesions in rats.Synapse. 2003 Dec 1;50(3):223-32. doi: 10.1002/syn.10265. Synapse. 2003. PMID: 14515340
-
Behavioral changes in rats with early ventral hippocampal damage vary with age at damage.Brain Res Dev Brain Res. 1997 Jul 18;101(1-2):17-25. doi: 10.1016/s0165-3806(97)00050-3. Brain Res Dev Brain Res. 1997. PMID: 9263576
Cited by
-
A plausible model of schizophrenia must incorporate psychological and social, as well as neuro developmental, risk factors.Dialogues Clin Neurosci. 2001 Dec;3(4):243-56. doi: 10.31887/DCNS.2001.3.4/ebramon. Dialogues Clin Neurosci. 2001. PMID: 22033679 Free PMC article.
-
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.Pharmacol Ther. 2009 May;122(2):150-202. doi: 10.1016/j.pharmthera.2009.02.004. Epub 2009 Mar 6. Pharmacol Ther. 2009. PMID: 19269307 Free PMC article. Review.
-
Consideration of species differences in developing novel molecules as cognition enhancers.Neurosci Biobehav Rev. 2013 Nov;37(9 Pt B):2181-93. doi: 10.1016/j.neubiorev.2012.10.002. Epub 2012 Oct 12. Neurosci Biobehav Rev. 2013. PMID: 23064177 Free PMC article. Review.
-
Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning.Neuropsychol Rev. 2001 Mar;11(1):45-67. doi: 10.1023/a:1009013718684. Neuropsychol Rev. 2001. PMID: 11392562 Review.
-
Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.Neuropsychopharmacology. 2006 Jan;31(1):77-89. doi: 10.1038/sj.npp.1300791. Neuropsychopharmacology. 2006. PMID: 15957008 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials